palliative radiotherapy
palliative radiotherapy is a radiation therapy with 20 clinical trials. Currently 9 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
6
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
9
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
High Dose Radiotherapy for Palliation (Hi-D)
Clinical Trials (20)
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
High Dose Radiotherapy for Palliation (Hi-D)
Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer
Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial
A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors
Radiotherapy & Combi in Metastatic Melanoma
Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET)
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Prognosis of Patient Evaluated for Palliative Radiotherapy
Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer
Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial
All 20 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 20